Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Kei MASUDA"'
Publikováno v:
Nihon Kikai Gakkai ronbunshu, Vol 87, Iss 899, Pp 21-00026-21-00026 (2021)
It will take a long time to put autonomous driving into practical in city road. Because the reliability of the technology for collecting traffic environment information and making appropriate driving judgment plans is still insufficient. Therefore, t
Externí odkaz:
https://doaj.org/article/5fc15933b3794cba80ccbc8b8e9fe01a
Autor:
Mizuho Nagao, Masanori Ikeda, Norimasa Fukuda, Chizu Habukawa, Tetsuro Kitamura, Toshio Katsunuma, Takao Fujisawa, Kennichi Tokuyama, Akihiko Terada, Kazuki Sato, Katsushi Miura, Hirokazu Arakawa, Masafumi Zaitsu, Tastuo Sakamoto, Tetsuya Takamasu, Naoki Shimojo, Makoto Kameda, Hiroyuki Mochizuki, Hiroshi Tachimoto, Koichi Yamaguchi, Kei Masuda, Yuichi Adachi, Yusei Oshima, Shigemi Yoshihara, Noriko Tanaka, Kunitaka Ohta, Masao Morita, Reiko Tokuda, Yoshihiko Kitou, Hayao Araki, Akiko Yamaoka, Akio Nakamura
Publikováno v:
Allergology International, Vol 67, Iss 1, Pp 72-78 (2018)
Background: While Japanese guideline recommends initial control treatment for preschool children with asthma symptoms more than once a month, Western guidelines do not. To determine whether control treatment with montelukast was more effective than a
Externí odkaz:
https://doaj.org/article/24b172e724694d7ab84e1b07ebf4f0df
Autor:
Kenichi Akashi, Hidetoshi Mezawa, Yuichi Tabata, Jun Atsuta, Reiko Tokuda, Yasusuke Kawada, Tetsuro Kitamura, Hiroko Murasugi, Hiroaki Ito, Masahiko Tabata, Kenichiro Shirao, Satoshi Sato, Hideko Nishimura, Masako Fujiwara, Kei Masuda, Hirokazu Arakawa, Yuichi Adachi, Shigemi Yoshihara, Takao Fujisawa, Toshio Katsunuma
Publikováno v:
Allergology International, Vol 65, Iss 3, Pp 306-311 (2016)
Background: Several guidelines, including the Japanese Pediatric Guideline for the Treatment and Management of Asthma (JPGL), recommend salmeterol/fluticasone combination therapy (SFC) as step 3 to 4 treatment for moderate to severe asthma. However,
Externí odkaz:
https://doaj.org/article/1ea434ccce7845c183cdabe4b5ad9ea4
Autor:
Toshio Katsunuma, Takao Fujisawa, Mizuho Nagao, Akira Akasawa, Ichiro Nomura, Akiko Yamaoka, Hisashi Kondo, Kei Masuda, Koichi Yamaguchi, Akihiko Terada, Masanori Ikeda, Kenji Nishioka, Yuichi Adachi, Kazuyuki Kurihara
Publikováno v:
Allergology International, Vol 62, Iss 1, Pp 37-43 (2013)
Background: Few studies have examined the efficacy or safety of a transdermal β2 agonist as add-on medicationto long-term leukotriene receptor antagonist (LTRA) therapy in pediatric asthma patients. Methods: In this randomized, open-label, multicent
Externí odkaz:
https://doaj.org/article/b14bca6ffa2a42d3892aacd9b88b15c4
Autor:
Aeson Chang, Edoardo Botteri, Ryan D. Gillis, Lukas Löfling, Caroline P. Le, Alexandra I. Ziegler, Ni-Chun Chung, Matthew C. Rowe, Stewart A. Fabb, Brigham J. Hartley, Cameron J. Nowell, Sasagu Kurozumi, Sara Gandini, Elisabetta Munzone, Emilia Montagna, Nina Eikelis, Sarah E. Phillips, Chikako Honda, Kei Masuda, Ayaka Katayama, Tetsunari Oyama, Steve W. Cole, Gavin W. Lambert, Adam K. Walker, Erica K. Sloan
Publikováno v:
Science Translational Medicine. 15
Beta-adrenergic blockade has been associated with improved cancer survival in patients with triple-negative breast cancer (TNBC), but the mechanisms of these effects remain unclear. In clinical epidemiological analyses, we identified a relationship b
Publikováno v:
bioRxiv
Ketamine, a rapid-acting anesthetic and acute antidepressant, carries undesirable spatial cognition side effects including out-of-body experiences and spatial memory impairments. The neural substrates that underlie these alterations in spatial cognit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63ec5a0ca0a7ddb34ccd216f669e30e2
https://doi.org/10.1101/2023.02.05.527227
https://doi.org/10.1101/2023.02.05.527227
Autor:
Tatsuhiko Fujimoto, Kentaro Rikimaru, Koichiro Fukuda, Hiromichi Sugimoto, Kei Masuda, Norio Ohyabu, Yoshihiro Banno, Norihito Tokunaga, Tetsuji Kawamoto, Yoshihide Tomata, Yasumi Kumagai, Motoo Iida, Yoichi Nagano, Mariko Yoneyama-Hirozane, Yuji Shimizu, Katsunori Sasa, Takashi Ishikawa, Hiroshi Yukitake, Mitsuhiro Ito, Kazunobu Aoyama, Takahiro Matsumoto
Publikováno v:
ACS Medicinal Chemistry Letters. 13:457-462
TAK-925, a potent, selective, and brain-penetrant orexin 2 receptor (OX2R) agonist, [methyl (2
Autor:
Tetsunari Oyama, Hideyuki Takahashi, Shota Ida, Yurino Nagata, Kei Masuda, Ikko Mito, Hideki Sezutsu, Toshiyuki Matsuyama, Masato Shino, Kazuaki Chikamatsu, Shigeki Takeda, Miho Uchida, Ken-Ichiro Tatematsu, Kanae Yamada, Hiroe Tada
Publikováno v:
Cancer Immunology, Immunotherapy. 71:851-863
Cancer immunotherapy using immune checkpoint inhibitors (ICIs) has been recognized as a novel therapeutic option for head and neck squamous cell carcinoma (HNSCC). However, only approximately 20-30% of patients with recurrent/metastatic (R/M) HNSCC b
Autor:
Kei Masuda
Publikováno v:
Nihon Shoni Arerugi Gakkaishi. The Japanese Journal of Pediatric Allergy and Clinical Immunology. 35:58-63
Autor:
Richard Tjhen, Noriko Uchiyama, Michiko Tawada, Yohei Kosugi, Satoshi Endo, Huikai Sun, Kei Masuda, Makoto Fushimi, Tatsuki Koike, Weston Lane
Publikováno v:
Journal of Medicinal Chemistry. 64:1103-1115
O-GlcNAcase (OGA) has received increasing attention as an attractive therapeutic target for tau-mediated neurodegenerative disorders; however, its role in these pathologies remains unclear. Therefore, potent chemical tools with favorable pharmacokine